Clinical Trials
Braintumor Website

There are 3 trials:
Facility: Saint Joseph Mercy Port Huron
NCT Trial Name# of Centers

NCT00892177

  Dasatinib and Bevacizumab in Treating Patients With Recurrent or Progressive High-Grade Glioma or Glioblastoma Multiforme
308

NCT01609790

  Bevacizumab With or Without Trebananib in Treating Patients With Recurrent Brain Tumors
175

NCT00329719

  Sorafenib and Temsirolimus in Treating Patients With Recurrent Glioblastoma
121



Home | Brain Tumor Guide | FAQs | Find A Treatment
Noteworthy Treatments | News | Virtual Trial | Videos | Novocure Optune® | Newsletter
Donations | Brain Tumor Centers | Survivor Stories | Temodar®
Fundraising For Research | Unsubscribe | Contact Us

Copyright (c) 1993 - 2017 by:
The Musella Foundation For Brain Tumor Research & Information, Inc
1100 Peninsula Blvd
Hewlett, NY 11557
888-295-4740


Website Design By
World Wide Websites